The global market for pain relief drugs is currently US$60 billion, and will grow to more than $80 billion by 2024, according to Transparency Market Research. This category of pharmaceuticals includes opioids, non-steroidal anti-inflammatory drugs (NSAIDS), anesthetics, analgesics and anti-depressants—treatments with side effects that can offset their therapeutic efficacy. It is no wonder conventional medicine is starting to experiment with non-drug therapies derived from foods and plants that have been safely consumed by humans for…
No comments:
Post a Comment